Akihiro Tomida

4.4k total citations
99 papers, 3.6k citations indexed

About

Akihiro Tomida is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Akihiro Tomida has authored 99 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Molecular Biology, 39 papers in Oncology and 25 papers in Cell Biology. Recurrent topics in Akihiro Tomida's work include Endoplasmic Reticulum Stress and Disease (24 papers), Cancer therapeutics and mechanisms (22 papers) and Drug Transport and Resistance Mechanisms (11 papers). Akihiro Tomida is often cited by papers focused on Endoplasmic Reticulum Stress and Disease (24 papers), Cancer therapeutics and mechanisms (22 papers) and Drug Transport and Resistance Mechanisms (11 papers). Akihiro Tomida collaborates with scholars based in Japan, South Korea and United States. Akihiro Tomida's co-authors include Takashi Tsuruo, T Tsuruo, Mikihiko Naito, Naomi Haga, Naoya Fujita, Tetsuo Mashima, Hiroyuki Suzuki, Hiroshi Sakamoto, Kazuo Shin‐ya and Yasunari Ogiso and has published in prestigious journals such as Journal of Biological Chemistry, Blood and ACS Nano.

In The Last Decade

Akihiro Tomida

97 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akihiro Tomida Japan 35 2.3k 929 686 676 407 99 3.6k
Moulay A. Alaoui‐Jamali Canada 42 3.1k 1.3× 1.3k 1.4× 792 1.2× 463 0.7× 378 0.9× 138 4.8k
Alakananda Basu United States 36 3.3k 1.4× 1.4k 1.5× 606 0.9× 457 0.7× 667 1.6× 109 5.1k
Joong Sup Shim Macao 33 3.2k 1.4× 994 1.1× 792 1.2× 1.3k 2.0× 287 0.7× 85 5.0k
William N. Hait United States 38 2.8k 1.2× 2.0k 2.1× 691 1.0× 536 0.8× 474 1.2× 92 4.8k
Georg Krupitza Austria 33 2.7k 1.2× 1.4k 1.5× 853 1.2× 449 0.7× 188 0.5× 134 5.0k
Ping Chen China 31 2.1k 0.9× 838 0.9× 728 1.1× 298 0.4× 315 0.8× 125 3.3k
Michael Grusch Austria 41 2.9k 1.2× 1.1k 1.2× 783 1.1× 292 0.4× 340 0.8× 161 4.7k
Dhyan Chandra United States 38 3.1k 1.3× 1.2k 1.3× 928 1.4× 412 0.6× 348 0.9× 71 4.8k
Cristiano Ferlini Italy 41 3.0k 1.3× 1.7k 1.9× 1.0k 1.5× 997 1.5× 263 0.6× 136 5.3k
Deliang Cao China 36 2.4k 1.0× 580 0.6× 1.0k 1.5× 1.2k 1.8× 223 0.5× 82 4.0k

Countries citing papers authored by Akihiro Tomida

Since Specialization
Citations

This map shows the geographic impact of Akihiro Tomida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akihiro Tomida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akihiro Tomida more than expected).

Fields of papers citing papers by Akihiro Tomida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akihiro Tomida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akihiro Tomida. The network helps show where Akihiro Tomida may publish in the future.

Co-authorship network of co-authors of Akihiro Tomida

This figure shows the co-authorship network connecting the top 25 collaborators of Akihiro Tomida. A scholar is included among the top collaborators of Akihiro Tomida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akihiro Tomida. Akihiro Tomida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuramochi, Kouji, Toshiki Furuya, Noritaka Kagaya, et al.. (2024). Cytochrome P450 2J2 is required for the natural compound austocystin D to elicit cancer cell toxicity. Cancer Science. 115(9). 3054–3066. 2 indexed citations
2.
Kunimasa, Kazuhiro, et al.. (2016). BRAF -mutated cells activate GCN2-mediated integrated stress response as a cytoprotective mechanism in response to vemurafenib. Biochemical and Biophysical Research Communications. 482(4). 1491–1497. 21 indexed citations
3.
Matsuo, Junichi, Yoshinori Tsukumo, Sakae Saito, et al.. (2012). Hyperactivation of 4E-Binding Protein 1 as a Mediator of Biguanide-Induced Cytotoxicity during Glucose Deprivation. Molecular Cancer Therapeutics. 11(5). 1082–1091. 18 indexed citations
4.
Ushijima, Masaru, Tetsuo Mashima, Akihiro Tomida, et al.. (2012). Development of a gene expression database and related analysis programs for evaluation of anticancer compounds. Cancer Science. 104(3). 360–368. 9 indexed citations
5.
Kim, Ju‐Young, Ji‐Hwan Hwang, Mi‐Ran Cha, et al.. (2010). Arctigenin blocks the unfolded protein response and shows therapeutic antitumor activity. Journal of Cellular Physiology. 224(1). 33–40. 62 indexed citations
6.
Saito, Sakae, Junko Sakurai, Asami Sakamoto, et al.. (2009). Chemical Genomics Identifies the Unfolded Protein Response as a Target for Selective Cancer Cell Killing during Glucose Deprivation. Cancer Research. 69(10). 4225–4234. 137 indexed citations
7.
Tsukumo, Yoshinori, Satomi Tsukahara, Sakae Saito, Takashi Tsuruo, & Akihiro Tomida. (2009). A Novel Endoplasmic Reticulum Export Signal. Journal of Biological Chemistry. 284(40). 27500–27510. 27 indexed citations
8.
Isomura, Minoru, Natsuo Oya, Seiji Tachiiri, et al.. (2008). IL12RB2 and ABCA1 Genes Are Associated with Susceptibility to Radiation Dermatitis. Clinical Cancer Research. 14(20). 6683–6689. 32 indexed citations
9.
Matsuo, Junichi, Yoshinori Tsukumo, Junko Sakurai, et al.. (2008). Preventing the unfolded protein response via aberrant activation of 4E‐binding protein 1 by versipelostatin. Cancer Science. 100(2). 327–333. 25 indexed citations
10.
Ogiso, Yasunari, et al.. (2000). Proteasome inhibition circumvents solid tumor resistance to topoisomerase II-directed drugs.. PubMed. 60(9). 2429–34. 103 indexed citations
11.
Seimiya, Hiroyuki, et al.. (1999). Hypoxia Up-Regulates Telomerase Activity via Mitogen-Activated Protein Kinase Signaling in Human Solid Tumor Cells. Biochemical and Biophysical Research Communications. 260(2). 365–370. 77 indexed citations
12.
Tomida, Akihiro, et al.. (1999). Glucose-regulated stresses cause degradation of DNA topoisomerase II? by inducing nuclear proteasome during G1 cell cycle arrest in cancer cells. Journal of Cellular Physiology. 180(1). 97–104. 21 indexed citations
13.
Mikami, Koji, Mikihiko Naito, Hideaki Yano, et al.. (1998). Immunological Quantitation of DT‐Diaphorase in Carcinoma Cell Lines and Clinical Colon Cancers: Advanced Tumors Express Greater Levels of DT‐Diaphorase. Japanese Journal of Cancer Research. 89(9). 910–915. 48 indexed citations
14.
Kataoka, Shiro, Mikihiko Naito, Akihiro Tomida, & Takashi Tsuruo. (1994). Resistance to Antitumor Agent-Induced Apoptosis in a Mutant of Human Myeloid Leukemia U937 Cells. Experimental Cell Research. 215(1). 199–205. 37 indexed citations
15.
Naito, Mikihiko, et al.. (1993). Enhancement of Reversing Effect of Cyclosporin A on Vincristine Resistance by Anti‐P‐glycoprotein Monoclonal Antibody MRK‐16. Japanese Journal of Cancer Research. 84(5). 489–492. 7 indexed citations
16.
Tomida, Akihiro, T Tatsuta, & Hideo Suzuki. (1991). Novel Mechanism of N‐Solanesyl‐N,N′‐bis(3,4‐dimethoxybenzyl)ethylenediamine in Potentiation of Antitumor Drug Action on Multidrug‐resistant and Sensitive Chinese Hamster Cells. Japanese Journal of Cancer Research. 82(1). 127–133. 1 indexed citations
17.
Tahara, Makoto, Akihiro Tomida, Toshio Nishimura, Hideyo Yamaguchi, & Hideo Suzuki. (1990). Resorthiomycin, a novel antitumor antibiotic. III. Potentiation of antitumor drugs and its mechanism of action.. The Journal of Antibiotics. 43(2). 138–142. 6 indexed citations
18.
Tomida, Akihiro & Hideo Suzuki. (1990). Synergistic Effect in Culture of Bleomycin‐group Antibiotics and N‐Solanesyl‐N, N’‐bis(3,4‐dimethoxybenzyl)ethylenediamine, a Synthetic Isoprenoid. Japanese Journal of Cancer Research. 81(11). 1184–1190. 3 indexed citations
19.
20.
Tomida, Akihiro, et al.. (1979). [Studies on serum parathyroid hormone using the radioimmunoassay "Eiken" kit (author's transl)].. PubMed. 27(5). 533–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Moulay A. Alaoui‐Jamali Breakdown of academic impact, for papers by Alakananda Basu Breakdown of academic impact, for papers by Joong Sup Shim Breakdown of academic impact, for papers by William N. Hait Breakdown of academic impact, for papers by Georg Krupitza Breakdown of academic impact, for papers by Ping Chen Breakdown of academic impact, for papers by Michael Grusch Breakdown of academic impact, for papers by Dhyan Chandra Breakdown of academic impact, for papers by Cristiano Ferlini Breakdown of academic impact, for papers by Deliang Cao
Rankless by CCL
2026